These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21424814)

  • 21. Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study.
    Iqbal K; Gifford KA; Ibbott G; Grant RL; Buzdar S
    J Appl Clin Med Phys; 2014 Jan; 15(1):4531. PubMed ID: 24423854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
    Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
    Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
    Boggula R; Jahnke L; Wertz H; Lohr F; Wenz F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1168-75. PubMed ID: 21093168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization and quality assurance of an image-guided radiation therapy system for intensity-modulated radiation therapy radiotherapy.
    Tsai JS; Micaily B; Miyamoto C
    Med Dosim; 2012; 37(3):321-33. PubMed ID: 22417899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.
    Kron T; Chesson B; Hardcastle N; Crain M; Clements N; Burns M; Ball D
    Br J Radiol; 2018 May; 91(1085):20170737. PubMed ID: 29446317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
    Kron T; Pham D; Roxby P; Rolfo A; Foroudi F
    Radiother Oncol; 2012 Jun; 103(3):293-8. PubMed ID: 22483676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT.
    McDermott LN; Wendling M; Sonke JJ; van Herk M; Mijnheer BJ
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1568-77. PubMed ID: 17394951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing.
    Taylor PA; Kry SF; Alvarez P; Keith T; Lujano C; Hernandez N; Followill DS
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):242-248. PubMed ID: 27084644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Image-guided in vivo dosimetry for quality assurance of IMRT treatment for prostate cancer.
    Wertz H; Boda-Heggemann J; Walter C; Dobler B; Mai S; Wenz F; Lohr F
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):288-95. PubMed ID: 17189077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Multicentre quality assurance of intensity-modulated radiation therapy planning: beware the benchmarker.
    Williams MJ; Bailey MJ; Forstner D; Metcalfe PE
    J Med Imaging Radiat Oncol; 2008 Jun; 52(3):303. PubMed ID: 18477127
    [No Abstract]   [Full Text] [Related]  

  • 32. Testing the methodology for dosimetry audit of heterogeneity corrections and small MLC-shaped fields: Results of IAEA multi-center studies.
    Izewska J; Wesolowska P; Azangwe G; Followill DS; Thwaites DI; Arib M; Stefanic A; Viegas C; Suming L; Ekendahl D; Bulski W; Georg D
    Acta Oncol; 2016 Jul; 55(7):909-16. PubMed ID: 26934916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of phantom-less IMRT delivery verification using Varian DynaLog files and R/V output.
    Agnew CE; King RB; Hounsell AR; McGarry CK
    Phys Med Biol; 2012 Nov; 57(21):6761-77. PubMed ID: 23032423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetry investigation of MOSFET for clinical IMRT dose verification.
    Deshpande S; Kumar R; Ghadi Y; Neharu RM; Kannan V
    Technol Cancer Res Treat; 2013 Jun; 12(3):193-8. PubMed ID: 23369153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
    Wilbert J; Baier K; Hermann C; Flentje M; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):237-42. PubMed ID: 22541958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom.
    Kron T; Hamilton C; Roff M; Denham J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):566-79. PubMed ID: 11872306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy and precision of cone-beam computed tomography guided intensity modulated radiation therapy.
    Sutton MW; Fontenot JD; Matthews KL; Parker BC; King ML; Gibbons JP; Hogstrom KR
    Pract Radiat Oncol; 2014; 4(1):e67-73. PubMed ID: 24621434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel method for dose distribution registration using fiducial marks made by a megavoltage beam in film dosimetry for intensity-modulated radiation therapy quality assurance.
    Nakayama S; Monzen H; Oonishi Y; Mizote R; Iramina H; Kaneshige S; Mizowaki T
    Phys Med; 2015 Jun; 31(4):414-9. PubMed ID: 25724351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPU-based ultrafast IMRT plan optimization.
    Men C; Gu X; Choi D; Majumdar A; Zheng Z; Mueller K; Jiang SB
    Phys Med Biol; 2009 Nov; 54(21):6565-73. PubMed ID: 19826201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: a report on the procedure, dosimetry and preliminary clinical outcome.
    Murthy V; Krishnatry R; Mallik S; Master Z; Mahantshetty U; Shrivastava S
    J Cancer Res Ther; 2013; 9(2):253-60. PubMed ID: 23771369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.